Filed with ASX · · 1 page · English
Investors and shareholders are invited to an online presentation following the report's release. This announcement has been authorized by the CEO.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
PO BOX Q1222 Queen Victoria Building Sydney, NSW 1230 1300 724 579 info@Pharmx.com.au www.Pharmx.com.au ABN: 25 000 091 305 ACN: 000 091 305 ASX Release 20 August 20 2 6 _________________________________________________________________________________________ Notice of...
PharmX Technologies Limited on 6ix
Follow PharmX Technologies into a list and get an email when it puts out news.
Follow PharmX Technologies